These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9765694)

  • 41. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
    Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
    Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose-rate intracavitary brachytherapy for gynecologic malignancies.
    Stitt JA
    Oncology (Williston Park); 1992 Jan; 6(1):59-70, 79; discussion 80-2. PubMed ID: 1531604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer.
    Mitra D; Klopp AH; Viswanathan AN
    Gynecol Oncol; 2016 Jan; 140(1):167-75. PubMed ID: 26432041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
    Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
    Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First two cases of primary carcinoma of the vagina successfully treated with concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high-dose-rate interstitial brachytherapy: a case report and published work review.
    Mabuchi S; Kawano M; Isohashi F; Kuroda H; Sasano T; Kimura T
    J Obstet Gynaecol Res; 2015 Jan; 41(1):156-61. PubMed ID: 25227150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer.
    Pearcey RG; Petereit DG
    Radiother Oncol; 2000 Jul; 56(1):17-22. PubMed ID: 10869750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
    Chong I; Hoskin PJ
    Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
    Small W; Erickson B; Kwakwa F
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
    Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
    Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ
    Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
    Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
    Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy.
    Kim H; Rajagopalan MS; Houser C; Beriwal S
    Brachytherapy; 2014; 13(3):263-7. PubMed ID: 24080298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
    Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mangiacotti MG; Margariti PA; Ferrandina G; Scambia G
    Tumori; 2005; 91(3):215-20. PubMed ID: 16206643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of vaginal cuff brachytherapy in endometrial cancer.
    Harkenrider MM; Block AM; Siddiqui ZA; Small W
    Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
    Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
    Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
    Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
    Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.
    Sorbe B; Nordström B; Mäenpää J; Kuhelj J; Kuhelj D; Okkan S; Delaloye JF; Frankendal B
    Int J Gynecol Cancer; 2009 Jul; 19(5):873-8. PubMed ID: 19574776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dosimetric comparison of optimization methods for multichannel intracavitary brachytherapy for superficial vaginal tumors.
    Lapuz C; Dempsey C; Capp A; O'Brien PC
    Brachytherapy; 2013; 12(6):637-44. PubMed ID: 23850274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.